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1. Introduction 
Successful use of liposomes as a drug carrier in 
vivo is often dependent on their prolonged presence 
in the blood [ 1,2]. This is expected to reduce uptake 
of liposomes by the reticuloendothelial system and 
allow them to deliver drugs to alternative cell targets 
[ 11. To this end, there has been modest success 
through the manipulation of liposomal surface charge 
[3] and size [4]. However, with liposomes that have 
little or no cholesterol, entrapped solutes leak out 
rapidly in the presence of blood. Solute leakage is 
effected through the loss of phospholipid molecules 
to plasma high density lipoproteins and ensuing 
bilayer destabilization [5-71. We have found that the 
presence of excess cholesterol in the bilayers greatly 
diminishes such phospholipid movement, thereby 
preserving their stability [7-91. Thus, solutes carried 
by neutral or positively charged small unilamellar 
cholesterol-rich liposomes composed of egg phospha- 
tidylcholine can attain a half-life in rodents (-2 h) 
which is similar to that exhibited by the carrier [4,7]. 
Here, we have investigated conditions that will 
allow circulating liposomes to extend their presence 
in the blood considerably and at the same time enable 
them to retain solutes quantitatively. Our data show 
that, for small unilamellar neutral liposomes, the half- 
life of their solute content in the circulation of mice 
can be controlled by the appropriate choice of the 
phospholipid component and the addition of excess 
cholesterol or its omission. Extended half-life (<16 h) 
of the solute is reflected in its reduced uptake by the 
liver and spleen. 
Abbreviations: egg PC, egg phosphatidylcholine; CF, carboxy- 
fluorescein, DLPC, dilauroyl phosphatidylcholine, DMPC, 
dimyristoyl phosphatidylcholine; DSPC, distearoyl phospha- 
tidylcholine, DOPC, dioleoyl phosphatidylcholine 
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2. Materials and methods 
The sources and grades of egg PC, cholesterol, CF 
and ‘11 In-labelled bleomycin (>lO mCi/pg In) have 
been described [7,9,10]. DLPC, DMPC, DSPC, DOPC 
and sphingomyelin were purchased from Sigma 
Chemical Co. All other reagents were of analytical 
grade. 
Small unilamellar liposomes (30-60 nm diam.) 
with entrapped CF or “‘In-labelled bleomycin were 
prepared [7] from 30 pmol phospholipid alone or 
supplemented with 30 pmol cholesterol (1: I molar 
ratio): after evaporation of the solvent CHCls under 
a stream of O*hfree nitrogen, the dry lipid film was 
disrupted with 0.25 M CF or a tracer of ‘l’In-labelled 
bleomycin dissolved in 1.5 ml 0.1 M sodium phos- 
phate containing 0.8% NaCl and 0.02% KC1 (phos- 
phate buffer, pH 7.4). The suspension was sonicated 
[7] for 10 min (1 min sonication with 30 s cooling 
periods) at 4’C (at 65°C when DSPC was used) and 
then centrifuged at 100 000 X g for 60 min. Separa- 
tion of CF- or “‘In-labelled bleomycin-containing 
small unilamellar liposomes in the supernatant from 
the untrapped materials was carried out on a 
Sepharose CL-6B (Pharmacia) column (1 X 25 cm) 
equilibrated with phosphate buffer and liposomes 
dialysed against the same buffer until their use, 
at most within 24 h following the gel filtration 
step. ‘I1 In in liposomes was measured as in [ 101 
and CF in suitably diluted samples assayed [9] in 
the absence (free dye) and presence (total dye) of 
Triton X-100 (1% final cont.) on a Perkin-Elmer 
fluorimeter using excitation and emission wave- 
lengths of 490 and 520 nm, respectively. The mini- 
mum amount of the dye that could be measured accu- 
rately was 4 ng/ml [7]. Latent CF serving as an index 
of liposomalstability [7,10,1 l] wasestimated [9] from 
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100 (Dye, - Dyet)/Dyet, where t and f denote total 
and free dye respectively. 
In in vitro experiments, I .O ml mouse (TO strain) 
heparinized fresh blood was incubated at 37°C with 
0.1 ml CF-containing liposomes. At time intervals, 
blood samples were centrifuged at 3000 rev./mm for 
10 min and plasma assayed for CF latency [9]. In 
other experiments, TO mice weighing 25-30 g were 
injected into the tail vein with 0.2 ml CF-containing 
liposomes and bled at time intervals. Plasma obtained 
from heparinized blood samples was then assayed [9] 
for total, free and latent CF. Mice injected as above 
with liposomes containing “‘In-labelled bleomycin 
were killed at 72 h and radioactivity was measured 
[IO] in blood, liver, spleen, lungs, kidney, brain and 
skeletal muscle. 
3. Results and discussion 
We have studied the effect of phospholipid com- 
position of small unilamellar liposomes on the rate 
of clearance of their solute contents from the blood 
of injected animals. To distinguish between the por- 
tion of solute in the circulation that is still entrapped 
from the portion that may have leaked out of lipo- 
somes, CF was chosen as a model solute: as CF 
quenches fully when entrapped at a high concentra- 
tion (e.g., 0.05-0.25 M) and fluoresces only upon 
its leakage and subsequent dilution in the surrounding 
medium [ 1 I], assay of quenched (latent) dye in the 
blood will allow accurate monitoring of liposomal CF 
levels. If CF leakage in the circulation is nil or mini- 
mal, its clearance rates should then be identical or, at 
least, similar to that of its carrier. Therefore, attempts 
have been made to reduce permeability of liposomes 
to entrapped solutes by the incorporation of excess 
cholesterol into their structure. As discussed in 
[7-91 this approach effectively reduces the blood- 
induced permeability of liposomes made of egg PC 
to a number of solutes. Data in table 1 show that cho- 
lesterol acts similarly for liposomes composed of a vari- 
ety of other phospho~pids althou~ for those made of 
DLPC the effect is less pronounced (49.4% latency, 
table 1). Indeed, the latency (86.5%) of liposomes 
made of DSPC alone is actually reduced (to 32.4%) 
by the incorporation of cholesterol, probably because 
of an increase in their fluidity [2] (table 1). 
Fig.1 shows the rates of clearance of entrapped CF 
from the circulation of mice injected with liposomes 
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Table 1 
The effect of the cholesterol content of liposomes on the 
latency of entrapped CF in the presence of blood 
Lipid composition CF latency (%) 
Dilauroyl phosphatidylcholine 
Dimyristoyl phosphatidylcholine 
Distearoyl phosphatidyIcholine 
Dioleoyl phosphatidylcho~ne 
Egg phosphatidylcholine 
Sphingomyelin 
Nil (58.0) 
Nil (66.8) 
86.5 (93.5) 
Nil (90.1) 
Nil (81.1) 
27.5 (96.6) 
Dilauroyl phosphatidylchohne, 
cholesterol 
Dimyristoyl phosphatidylcho~ne, 
49.4 (96.7) 
cholesterol 
Distearoyl phosphatidylcholine, 
94.7a (99.2) 
cholesterol 
Dioleoyl phosphatidylcho~ne, 
32.4’ (98.9) 
cholesterol 88.4 (97.5) 
Egg phosphatidylcholine, cholesterol 86.3 (97.0) 
Sphingomyelin, cholesterol 97.6b (98.8) 
a Incubated for 6 h; b . mcubated for 12 h; ’ 1:0.25 phospho- 
1ipid:chobsterol molar ratio 
SmalI unilamellar liposomes (2 pmol phospholipid) composed 
of various phosphollpids without or with cholesterol (1 :l 
molar ratio) and containing 0.25 M CF, were incubated with 
10 vol. mouse heparinized fresh blood at 37°C for 1 h unless 
otherwise stated. Typical CF latency values shown here are 
means of duplicate readings and are expressed as % of the 
Iatencies (shown in parentheses) of the respective liposomat 
preparations 
exhibiting minimum CF leakage in the presence of 
blood (see table 1). Half-lives of the dye range from a 
minimum of 0.1 h to a maximum of 16 h for lipo- 
somes made of DLPC and sp~ngomyelin, respectively 
and, in the latter case, this corresponds to an -8OO- 
fold increase over the half-life (G.2 min) [7] of the 
free CF. Since there is inevitably some leakage of CF 
into the circulation, half-lives of the entrapped dye 
are likely to be, especially for liposomes made of 
DLPC, underestimates of those for the respective 
liposomal preparations. Interestingly, there is no 
obvious relationship between clearance rates of the 
liposomal dye and physical characteristics of the 
component phospholipids. For instance, DPLC, 
DMPC and DSPC are all saturated phospholipids with 
fatty acid esters of increasing length yet, respective 
half-lives of liposomal CF are 0.1,6 and 1.5 h. Simi- 
larly, although both DOPC and egg PC are unsatu- 
rated phospholipids, half-lives (1 and 2 h, respec- 
tively) of liposomal CF overlap with those observed 
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Fig.1. The effect of the phospholipid component of lipo- 
somes on the clearance of entrapped CF from the blood of 
injected mice. Mice were bled at time intervals after intra- 
venous injection of CF entrapped in small unilamellar lipo- 
somes (3 mg phospholipid) composed of dilauroyl phospha- 
tidylcholine (A), dioleoyl phosphatidylcholine (A), distearoyl 
phosphatidylcholine (o), egg phosphatidylcholine (*), dimyr- 
istoyl phosphatidylcholine (m) or sphingomyelin (0). With 
the exception of liposomes made of distearoyl phosphatidyl- 
choline, all preparations contained cholesterol (1:l molar 
ratio). Latent CF values (means from 3 animals) in total 
mouse plasma are expressed as % of latent CF injected 
(SE 23% are shown). Half-lives estimated from slopes were 
DLPC, O.l;DOPC, l;DSPC, 1S;egg PC, 2;DMPC, (i;sphingo- 
myelin, 16 h. 
for saturated DSPC and DMPC (1.5 and 6 h, respec- 
tively). 
Differences in liposomal solute survival in the cir- 
culation, effected by the nature of the phospholipid 
component of liposomes, are expected to reflect the 
extent of solute uptake by the liver and spleen. In 
studies (fig.2) on tissue distribution of liposomal 
solutes, we have used as a model solute “‘In-labelled 
bleomycin. , ‘llIn unlike CF (unpublished) persists 
in tissues for several days [lo] thus allowing exami- 
nation of their radioactivity levels at a time when 
blood is devoid of circulating liposomes. The total 
amount of the solute delivered to tissues by a given 
liposomal preparation can therefore be measured. 
From fig.2, for liposomal preparations which progres- 
sively increase the half-life of the solute they carry 
(e.g., those made of egg PC, DMPC and sphingo- 
myelin; fig.l), transport of their radioactivity to the 
liver is accordingly decreased. Thus, hepatic uptake 
of lllIn is reduced from -32% (egg PC liposomes) 
to 23% (DMPC liposomes) and to 16% for sphingo- 
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Fig.2. Effect of the phospholipid component of liposomes on 
the uptake of entrapped ‘I1 In-labelled bleomycin by tissues 
of injected mice. Mice were killed 72 h after the intravenous 
injection of “‘In-labelled bleomycin (lo’-2 X 10’ cpm) 
entrapped in small unilamellar liposomes (3 mg phospholipid) 
composed of egg phosphatidylcholine (open bars), dimyris- 
toy1 phosphatidylcholine (dotted bars) or sphingomyelin 
(shaded bars). All preparations contained cholesterol (1 :l 
molar ratio). rLIIn radioactivity values (means from 3 ani- 
mals) are expressed as % GE of the injected dose/g tissue. 
Organ weights in 12 mice were 0.53 * 0.01 (kidney), 1.7 f 0.05 
(liver) and 0.12 f 0.01 g (spleen). Radioactivity levels in the 
total plasma of mice at death were <4% and in brain, lungs 
and skeletal muscle <OS, 4.0 and 1 .O% of the injected dose/g 
tissue. 
myelin liposomes. Considerable reduction of radio- 
activity uptake for the latter preparation is also 
observed in the case of spleen (fig.2). In contrast, 
uptake of “‘In by kidney is greater when the long- 
lived sphingomyelin liposomes are given, probably 
because of the prolonged, albeit minor, leakage of 
radioactivity in the blood and its subsequent excre- 
tion into the urine [lo]. 
Whatever the surface properties of liposomes that 
enable some preparations to persist in the blood 
longer than others, these must be considered in con- 
junction with the mechanism(s) responsible for the 
recognition and uptake of liposomes by the liver and 
spleen. It has been shown, for instance, that plasma 
components such as ai-macroglobulin [ 121 and other 
proteins [ 131 coat liposomes upon contact and it 
may be that this opsonizes them for phagocytosis by 
45 
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the reticuloendothelial system. It is conceivable that 
the efficiency of this process is reduced by certain 
phospholipids and increased by others. Whilst events 
controlling liposome clearance from the circulation 
await elucidation, it is apparent from this and other 
studies [7-9,14-l 71 that appropriate choice of lopo- 
somal size, surface charge and composition can con- 
tribute to the design of liposomes suitable for realistic 
attempts at therapy. 
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